Søren Hough - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Søren Hough's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Søren Hough

Søren Hough

Verified

Editor, Informa Connect

London

Biography

Chaz Ebert — writer, publisher, and wife of the late critic Roger Ebert — once called me "a hipster scientist and film critic." I am a science writer and editor with a passion for positioning scientific research within its social context. I have led multiple teams of journalists at international publications toward creating premiere resources for accurate information on emerging technologies. I am comfortable writing for both general and expert audiences with a goal of making complex ideas understandable and engaging for readers. I am eager to rejoin the newsroom to bring a socially conscious perspective to critical issue like climate change and genome editing. I completed my PhD in Biochemistry in 2023.

Final Covers

politics ethics, Film, Science, television history

Doesn’t Cover

Stocks and bond markets.

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 26

  • Boehringer invests $30 million into antibody drug conjugate research and development

    By Søren Hough| BioProcess International Magazine Verified Søren Hough, Editor, Drug Modalities at Tides GlobalBoehringer invests $30 million in ADCsstock.adobe.comIn Basel, Switzerland, Boehringer Ingelheim has invested CHF 27 million ($31.5 million) in antibody drug conjugate (ADC) development by opening a new research facility dedicated to the modality. The facility will operate under Boehringer’s subsidiary company, NBE Therapeutics, which it acquired for over $1 billion in 2020.

    By Søren Hough · BioProcess International Magazine

    Apr. 11, 2025

  • FDA vaccine expert resigns, citing ‘irresponsible, detrimental’ RFK, Jr.

    By Søren Hough| BioProcess International Magazine Verified Peter Marks, an oncologist physician who holds medical and research doctorates, was one of the leading Center for Biologics Evaluation and Research (CBER) figures at the US Food and Drug Administration (FDA). His work spanned cell and gene therapy and pandemic response efforts – particularly including vaccine development. Now, he’s resigned, and his public statement points the finger directly at Department Health and Human Services (HHS) Secretary Robert F.

    By Søren Hough · BioProcess International Magazine

    Mar. 31, 2025

  • Leadership turnover roils US regulatory agencies

    By Søren Hough| bioxconomy.com@ The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) are two of the most critical players in US public health. They have key roles within the Department of Health and Human Services (HHS) in protecting the population from outbreaks and harmful medicines. They collectively employ nearly 30,000 scientists and other public health and policy experts.  President Trump made an earthquake statement when he appointed Robert F.

    By Søren Hough · bioxconomy.com

    Mar. 31, 2025

As seen in

Company Info

Informa Connect

London, England, United Kingdom

'+44 20 7017 5000

Søren Hough - Profile and Journalist Details